At Infusionine, we’ve accomplished what was once thought impossible—defying the limits of chemistry to develop the world’s first ready-to-drink Nicotinamide Mononucleotide (NMN) beverage. Our innovative, patent-pending stabilisation process ensures that 500 milligrams of NMN remains stable in 300ml ...See more
Headquarters:
Company Type:
SME
Company size:
1-10 Employees
Address:
null
LOW
spending power